TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hyperion DeFi ( (HYPD) ) has provided an update.
On October 27, 2025, Hyperion DeFi entered a Joint Validator Agreement with Kinetiq Research and Pier Two to operate a co-branded validator node on the Hyperliquid blockchain, effective retroactively from June 25, 2025. This agreement involves shared responsibilities and revenue-sharing arrangements, enhancing Hyperion’s operational capacity and market positioning in blockchain validation. Additionally, Hyperion announced a strategic partnership with Felix to launch a perpetual futures market on the Hyperliquid protocol, leveraging 500,000 HYPE tokens. This partnership aims to expand Hyperliquid’s product suite and revenue streams, marking a significant step in decentralized finance innovation.
The most recent analyst rating on (HYPD) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Hyperion DeFi stock, see the HYPD Stock Forecast page.
Spark’s Take on HYPD Stock
According to Spark, TipRanks’ AI Analyst, HYPD is a Neutral.
Eyenovia’s stock score is primarily impacted by its poor financial performance, with significant operational losses and a weak balance sheet. The technical analysis indicates a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors collectively result in a low overall stock score.
To see Spark’s full report on HYPD stock, click here.
More about Hyperion DeFi
Hyperion DeFi, Inc. is the first U.S. publicly listed company focused on building a strategic treasury of Hyperliquid’s native token, HYPE. The company provides investors with access to the Hyperliquid ecosystem, a rapidly growing blockchain known for high revenue generation. Hyperion DeFi is also developing the Optejet User Filled Device for ophthalmic liquids, which aims to improve treatment compliance and outcomes.
Average Trading Volume: 767,246
Technical Sentiment Signal: Sell
Current Market Cap: $45.93M
For detailed information about HYPD stock, go to TipRanks’ Stock Analysis page.